发明公开
- 专利标题： ANTI-SIGLEC-15 ANTIBODY
-
申请号： EP20165057.9申请日： 2010-04-07
-
公开(公告)号： EP3699277A1公开(公告)日： 2020-08-26
- 发明人: HIRUMA, Yoshiharu , TSUDA, Eisuke , NAKAYAMA, Maikiko , TAKIZAWA, Takeschi
- 申请人： Daiichi Sankyo Company, Limited
- 申请人地址： 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 JP
- 专利权人： Daiichi Sankyo Company, Limited
- 当前专利权人： Daiichi Sankyo Company, Limited
- 当前专利权人地址： 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426 JP
- 代理机构： Arends, William Gerrit
- 优先权： JP2009094613 20090409
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K39/395 ; A61P1/02 ; A61P3/14 ; A61P19/08 ; A61P19/10 ; A61P35/00 ; A61P35/04 ; C07K16/18 ; C07K16/46 ; C12N1/15 ; C12N1/19 ; C12N1/21 ; C12N5/10 ; C12P21/08 ; A61K39/00 ; A61P19/02 ; C07K16/28
摘要：
Provided is a pharmaceutical composition for treating and/or preventing abnormal bone metabolism targeting a protein encoded by a gene strongly expressed in osteoclasts. Specifically provided is a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation, and the like.
信息查询
IPC分类:
